Allogene Therapeutics: 4Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $61 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 58 cents.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
For the year, the company reported that its loss narrowed to $184.6 million, or $1.83 per share.
Allogene Therapeutics shares have fallen 2% since the beginning of the year. The stock has dropped 20% in the last 12 months.